Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug SensitivityKevin Lin, Kris C. Wood, Abigail Xie et al.|Cell Metabolism|2019Cited by 112
A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patientsLeylah Drusbosky, Christopher R. Cogle, Glenda G. Anderson et al.|Blood Advances|2019Cited by 15
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam Nguyen, Jatinder K. Lamba|Blood Advances|2022Cited by 15
Heterogeneous Nuclear Ribonucleoprotein C is an Indispensable Target in Acute Myeloid LeukemiaVindhya Vijay, Christopher R. Cogle, Amy Meacham et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1